Literature DB >> 8660969

Sequence, genomic structure, and chromosomal assignment of human DOC-2.

H M Albertsen1, S A Smith, R Melis, B Williams, P Holik, J Stevens, R White.   

Abstract

DOC-2 is a human gene originally identified as a 767-bp cDNA fragment isolated from normal ovarian epithelial cells by differential display against ovarian carcinoma cells. We have now determined the complete cDNA sequence of the 3.2-kb DOC-2 transcript and localized the gene to chromosome 5. A 12.5-kb genomic fragment at the 5'-end of DOC-2 has also been sequenced, revealing the intron-exon structure of the first eight exons (788 bases) of the DOC-2 gene. Translation of the DOC-2 cDNA predicts a hydrophobic protein of 770 amino acid residues with a molecular weight of 82.5 kDa. Comparison of the DNA and amino acid sequences of DOC-2 to publicly accessible sequence databases revealed 83% identify to p96, a murine protein of similar size, thought to be a mitogen-responsive phosphoprotein. In addition, about 45% identity was observed between the first 140 N-terminal residues of DOC-2 and the Caenorhabditas elegans M110.5 and Drosophila melanogaster Dab genes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8660969     DOI: 10.1006/geno.1996.0185

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  9 in total

1.  Disabled homolog 2 controls macrophage phenotypic polarization and adipose tissue inflammation.

Authors:  Samantha E Adamson; Rachael Griffiths; Radim Moravec; Subramanian Senthivinayagam; Garren Montgomery; Wenshu Chen; Jenny Han; Poonam R Sharma; Garrett R Mullins; Stacey A Gorski; Jonathan A Cooper; Alexandra Kadl; Kyle Enfield; Thomas J Braciale; Thurl E Harris; Norbert Leitinger
Journal:  J Clin Invest       Date:  2016-02-29       Impact factor: 14.808

2.  Disabled-2 is transcriptionally regulated by ICSBP and augments macrophage spreading and adhesion.

Authors:  Frank Rosenbauer; Axel Kallies; Marina Scheller; Klaus-Peter Knobeloch; Charles O Rock; Maike Schwieger; Carol Stocking; Ivan Horak
Journal:  EMBO J       Date:  2002-02-01       Impact factor: 11.598

Review 3.  The High Mobility Group A1 (HMGA1) Transcriptome in Cancer and Development.

Authors:  T F Sumter; L Xian; T Huso; M Koo; Y-T Chang; T N Almasri; L Chia; C Inglis; D Reid; L M S Resar
Journal:  Curr Mol Med       Date:  2016       Impact factor: 2.222

4.  Deficiency of Dab2 (Disabled Homolog 2) in Myeloid Cells Exacerbates Inflammation in Liver and Atherosclerotic Plaques in LDLR (Low-Density Lipoprotein Receptor)-Null Mice-Brief Report.

Authors:  Samantha E Adamson; Renata Polanowska-Grabowska; Kathryn Marqueen; Rachael Griffiths; Jerry Angdisen; Sarah R Breevoort; Ira G Schulman; Norbert Leitinger
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-03-29       Impact factor: 8.311

5.  Cytosolic adaptor protein Dab2 is an intracellular ligand of endocytic receptor gp600/megalin.

Authors:  A V Oleinikov; J Zhao; S P Makker
Journal:  Biochem J       Date:  2000-05-01       Impact factor: 3.857

6.  Alternative splicing modulates Disabled-1 (Dab1) function in the developing chick retina.

Authors:  Sachin Katyal; Roseline Godbout
Journal:  EMBO J       Date:  2004-04-01       Impact factor: 11.598

7.  Identifying Dendritic Cell-Related Genes Through a Co-Expression Network to Construct a 12-Gene Risk-Scoring Model for Predicting Hepatocellular Carcinoma Prognosis.

Authors:  Chaoyuan Huang; Xiaotao Jiang; Yuancheng Huang; Lina Zhao; Peiwu Li; Fengbin Liu
Journal:  Front Mol Biosci       Date:  2021-05-24

8.  miR-106b targets DAB2 to promote hepatocellular carcinoma cell proliferation and metastasis.

Authors:  Chunhui Sun; Xun Yao; Qingyu Jiang; Xiuyong Sun
Journal:  Oncol Lett       Date:  2018-06-15       Impact factor: 2.967

Review 9.  Emerging Roles of Disabled Homolog 2 (DAB2) in Immune Regulation.

Authors:  Vanessa Figliuolo da Paz; Fayez K Ghishan; Pawel R Kiela
Journal:  Front Immunol       Date:  2020-10-15       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.